Previous Page  30 / 32 Next Page
Information
Show Menu
Previous Page 30 / 32 Next Page
Page Background

Rationale for using osimertinib first

Greater therapeutic efficacy and good toxicity profile

Higher CNS activity

No need for T790M determination